Adalvo CEO, Anil Okay nominated as finalist for CEO of the year award

Adalvo are honored to have been recognized by CPhI Pharma, where our CEO, Anil Okay, has been nominated as a finalist for the CEO of the Year Award!

Adalvo are honored to have been recognized by CPhI Pharma, where our CEO, Anil Okay, has been nominated as a finalist for the CEO of the Year Award!

The CPhI Pharma Awards celebrate the thinkers and creators driving the industry forward through their innovations, technologies, and strategies.

This esteemed nomination is a testament to Anil's visionary leadership and the remarkable journey Adalvo have embarked on under his guidance.

Anil proudly claimed this very award in 2021, demonstrating his enduring dedication to advancing the pharmaceutical industry.

Winners will be announced at the Awards Ceremony taking place on the 24th October at Hall Botanica (East Entrance, next to Hall 3), Fira Barcelona Gran Via, Spain.

In addition to Anil's nomination, Adalvo has received further nominations in the esteemed categories of Drug Delivery & Device and Finished Formulation. These nominations confirm Adalvo's dedication to pushing the boundaries of pharmaceutical innovation across diverse domains.

We would to extend our congratulations to all other nominees and look forward to seeing you there!
Partner Up Now!

At Adalvo, there are no half-measures – we are always on target. When your mission is to be faster and stronger than your competitors, you need a winning team driving your vision forward.

[email protected] - Head of Global BD&L

[email protected] - LATAM (exc. Brazil)

[email protected] - South Europe

[email protected] – Central & Eastern Europe, Russia & CIS

[email protected] North Europe, APAC, MENA & Israel

[email protected] - Central and Western Europe

[email protected] – Europe

[email protected] – UK/Ireland, North America & South Africa

Click on your preferred Business Partner and get in touch today!